高级检索
当前位置: 首页 > 详情页

1H NMR-based metabonomic revealed protective effect of Moutan Cortex charcoal on blood-heat and hemorrhage rats.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Traditional Chinese Medicine, Guangdong Pharmaceutical University, The Key Unit of Chinese Medicine Digitalization Quality Evaluation of State Administration of Traditional Chinese Medicine, The Research Center for Quality Engineering Technology of Traditional Chinese Medicine, Guangzhou, China. [2]Guangzhou Medical University Cancer Hospital and Institute, Guangzhou, Guangdong, China.
出处:
ISSN:

关键词: Moutan Cortex charcoal Metabonomic1 H NMR Pharmacodynamic biomarkers Action mechanism

摘要:
Moutan Cortex charcoal (MCC), the processed root bark of Paeonia suff ;ruticosa Andrews (Paeoniaceae), is a kind of traditional Chinese medicine (TCM) and has been used for treating blood-heat and hemorrhage(BHH)syndrome in China for thousands of years. In order to explore potential metabolic mechanism, 1H NMR-based metabonomics technique was applied to evaluate the effect of MCC on metabolic changes in plasma and urine of BHH rat models. Serum and urine samples were obtained from male SD rats with normal group, model group and MCC group for study. Based on 1H NMR spectra obtained from plasma and urine samples, principal component analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) models were capable of distinguishing the three group. And the 13 pharmacodynamic biomarkers of MCC were identified in the plasma and urine. The results showed that BHH induced great metabolic disorders in plasma and urine metabolisms. However, MCC could reverse the imbalanced metabolites by alanine, aspartate and glutamate metabolism and citrate cycle (TCA cycle) pathway, and its effect was also confirmed by the general signs and pharmacodynamics assessments. The results indicated that NMR-based metabolomic profiling method is sensitive and specific enough to evaluate the MCC efficacy and mechanism of action on BHH syndromes. Copyright © 2019. Published by Elsevier B.V.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 医学
小类 | 2 区 分析化学 3 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 分析化学 3 区 药学
第一作者:
第一作者机构: [1]Department of Traditional Chinese Medicine, Guangdong Pharmaceutical University, The Key Unit of Chinese Medicine Digitalization Quality Evaluation of State Administration of Traditional Chinese Medicine, The Research Center for Quality Engineering Technology of Traditional Chinese Medicine, Guangzhou, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Traditional Chinese Medicine, Guangdong Pharmaceutical University, The Key Unit of Chinese Medicine Digitalization Quality Evaluation of State Administration of Traditional Chinese Medicine, The Research Center for Quality Engineering Technology of Traditional Chinese Medicine, Guangzhou, China. [*1]College of Traditional Chinese Medicine of GuangdongPharmaceutical University, Guangzhou, Guangdong, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号